Matthias Lemke, MD
- 2Articles
- 7.4KReads1
- 2007–2010Active
- 29Collaborators
- 84Citations2
About
Matthias Lemke, MD, has published research focused on treatment strategies for first-episode schizophrenia and schizoaffective disorders. His work includes randomized controlled trials examining relapse prevention and maintenance drug treatments, specifically comparing risperidone and low-dose haloperidol. Lemke's studies, published between 2007 and 2010, contribute to clinical understanding within the German Research Network on Schizophrenia.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
